Transforming Healthcare Through Innovative Medical Devices
InnoTree is an incubator and accelerator focused on medical devices, digital health and diagnostic companies. Our team brings extensive experience and strong expertise to manage every phase of product development and commercialization.
Our mission is to enhance patients' lives by accelerating the growth of innovative companies that are transforming the healthcare system.
We envision a world where the innovative potential of every physician and healthcare professional is fully realized, no longer constrained by bureaucratic, technical or financial barriers. InnoTree acts as the catalyst that elevates clinical ingenuity to a new dimension, transforming it into products that shape the future of medicine.
We believe that true breakthroughs do not emerge from isolated laboratories, but from the meeting of frontline clinical experience and managerial excellence. Our goal is to create an ecosystem of sustainable and unprecedented innovation, where every device we incubate is more than a product: it is proof that collaboration between visionaries and pragmatists can redefine standards of care, saving and improving countless lives.
Our Mission is to bring physicians' clinical insights to life, transforming them into innovative and accessible medical devices. As an incubator of excellence, we combine the clinical expertise and creativity of healthcare professionals with our deep managerial and scientific knowledge.
We support physicians at every stage of development: from initial idea validation through design, production, and market launch. Our objective is to break down traditional barriers and accelerate the creation of devices that not only enhance patients' quality of life but also optimize medical procedures.
Driven by a passion for innovation and strong management capabilities, we translate research and development into tangible, scalable results. We aim to be the bridge that connects clinical genius with engineering expertise and entrepreneurial vision, redefining the future of medicine.
We scout, assess and validate promising ideas and technologies in the medical field, estimating market size and evaluating feasibility, clinical impact and patient benefit.
We provide a nurturing environment for medical technology startups, guiding them from concepts to market launch across the entire product lifecycle.
InnoTree supports startups in transforming concepts into functional prototypes, collaborating with experts to refine designs and ensure safety and efficacy.
We assist in establishing new companies, offering mentorship, legal guidance and business development support.
Raising capitals is critical for startups. InnoTree connects companies with investors, venture capitalists and strategic partners to secure funding.
Product concept with KOL (Key Opinion Leaders) support and pre-clinical validation
R&D and prototyping
Process development
Regulatory and Clinical strategy
Financial services
Strategic and legal planning
Product development and Supply Chain management
Product commercialization (Global Sales & Marketing)
InnoTree collaborates with leading players across the medical technology innovation ecosystem. We are part of a research, innovation and financial network that accelerates solutions addressing health security challenges. Through our accelerator program, we support selected companies with tailored commercialization strategies.
Innovative solutions for the treatment of cardiogenic shock and high risk PCI.
InnoTree is developing a next-generation circulatory support technology designed to address the unmet clinical needs between conventional intra-aortic balloon pumps and more complex mechanical support systems. This innovative, balloon- and gas-free hemodynamic support system utilizes counter-phasic retrograde blood flow to support patients with heart failure.
A Critical Challenge in Cardiovascular Care
Cardiogenic shock remains one of the most severe cardiovascular emergencies, with significant mortality despite advances in modern medicine.
Current mechanical circulatory support options often require clinicians to balance effectiveness, complexity, invasiveness, and cost.
There is a growing need for innovative solutions capable of expanding access to advanced circulatory support while maintaining clinical practicality and economic sustainability.
Bridging the Gap
At InnoTree, we believe that the next generation of circulatory support should be:
Our mission is to contribute to improved patient outcomes by developing advanced technologies that support clinicians in the management of acute cardiovascular conditions.
From Research to Clinical Innovation
The project combines expertise in:
Development activities include computational simulations, laboratory testing, preclinical validation, and preparation for future clinical studies.
A Multidisciplinary Ecosystem for Innovation
The development of InnoTree's technology is driven by a multidisciplinary network of clinicians, biomedical engineers, researchers, and industrial partners working together to address one of the most challenging conditions in cardiovascular medicine.
The project benefits from collaborations with leading Italian institutions, including:
These organizations contribute expertise spanning cardiovascular medicine, biomedical engineering, computational modeling, preclinical research, translational science, and medical device development.
Alongside academic and clinical partners, the project is supported by a network of highly specialized Lombardy-based SMEs, providing advanced competencies in:
The combination of scientific excellence, clinical expertise, and industrial know-how creates a strong foundation for transforming innovative concepts into future healthcare solutions.
Building the Future Together
InnoTree is currently engaging with institutional and private investors to support the next phases of technology development and validation.
We welcome discussions with:
We believe collaboration is essential to accelerate innovation and bring transformative technologies to patients.
Let's Connect
Whether you are a clinician, researcher, industrial partner, or investor, we would be pleased to discuss potential collaboration opportunities.
Informazioni ai sensi dell'art. 25, commi 11 e 12, D.L. 179/2012 (conv. L. 221/2012)
Ultimo aggiornamento: 25.09.2026
INNOTREE S.R.L. è iscritta nella sezione speciale del Registro delle Imprese di Milano Monza Brianza Lodi dedicata alle start-up innovative dal 22/09/2026.
| Data atto di costituzione | 08/09/2025 |
|---|---|
| Luogo e notaio | Milano, Studio Gasparro Frattini e Associati |
| Iscrizione Registro Imprese | Sezione ordinaria dal 03/12/2025 · sezione speciale start-up innovative dal 22/09/2026 |
Sede legale: Via della Resistenza 121/B, 20090 Buccinasco (MI). Nessuna sede secondaria.
Sviluppo, produzione e commercializzazione di prodotti e servizi innovativi ad alto valore tecnologico, in particolare: ricerca e sviluppo sperimentale nel campo dei dispositivi medici e delle tecnologie biomedicali; progettazione, prototipazione, validazione preclinica e clinica e produzione, anche tramite terzi, di dispositivi medici; sviluppo di software e sistemi di intelligenza artificiale in ambito sanitario; generazione e valorizzazione di privative industriali; conduzione di progetti di ricerca industriale e sviluppo sperimentale in collaborazione con università, IRCCS e centri di ricerca; servizi tecnico-scientifici connessi.
(Sintesi; il testo integrale è riportato nello statuto depositato presso il Registro Imprese, atto del 07/09/2026.)
La società svolge attività di ricerca e sviluppo nel settore dei dispositivi medici cardiovascolari, con particolare riferimento a un nuovo sistema di contropulsazione per il supporto temporaneo della funzione cardiocircolatoria, attualmente in fase di ricerca, prototipazione e verifica sperimentale, non ancora destinato alla commercializzazione né all'utilizzo clinico.
| Codice ATECO 2025 | 72.10.29 – Ricerca e sviluppo sperimentale (altre scienze naturali e ingegneria) |
|---|---|
| Spese in R&S – esercizio 2025 | Si attesta che nel corso dell'esercizio non sono stati sostenuti costi per attività di ricerca e sviluppo |
| Socio | Quota nominale (€) | % | Diritto |
|---|---|---|---|
| CGA S.R.L. (C.F. 11066760965) | 4.125,00 | 27,5% | Proprietà |
| Fabio Barletta | 4.125,00 | 27,5% | Proprietà |
| Emanuele Meliga | 2.625,00 | 17,5% | Proprietà |
| Fabrizio Bertoli | 2.625,00 | 17,5% | Proprietà |
| Fabio Sabbione | 1.500,00 | 10,0% | Proprietà |
| Totale capitale sociale | 15.000,00 | 100% |
Tra i soci non figurano società fiduciarie né holding.
Nessuna.
| Nominativo | Titoli ed esperienze |
|---|---|
| Fabio Sabbione | Laurea in Economia aziendale (Università di Pavia); Executive MBA (Politecnico di Milano). Amministratore unico. |
| Fabrizio Bertoli | Laurea in Tecniche sanitarie (Università di Chieti). |
| Emanuele Meliga | Laurea in Medicina (Università di Torino). |
| Fabio Barletta | Diploma. |
| Giorgio Sem | Diploma. |
Nessuna.
Bilancio al 31/12/2025, depositato presso il Registro Imprese.
| Titolo | Domanda n. | Deposito | Titolare |
|---|---|---|---|
| Catetere di contropulsazione migliorato | 102025000033784 | 17/12/2025 | INNOTREE S.R.L. |
If you are a healthcare professional or a medical-device startup with a transformative idea, consider joining InnoTree. Together we can create innovations that benefit patients and deliver lasting improvements in healthcare value.
CEO & CO-FOUNDER
Expert in launching new therapies and driving business growth in the structural heart field. He has worked in four start-ups, three acquired by multinational companies. Covering technical, clinical, commercial roles and supporting market development across multiple countries.
CO-Founder
Interventional Cardiologist with extensive experience in complex coronary and structural heart procedures. Member of the ESC Task Force for ACS and co-author of the 2020 ESC Guidelines for NSTE-ACS, he has published widely and contributed as a clinical trialist to the development of innovative cardiovascular therapies.
COO & Co-Founder
Executive with more than 20 years of international experience in medical device development and strategic management. He has led teams in bringing innovative technologies to market, combining product strategy, operational leadership, and deep expertise in healthcare innovation.
CFO & Co-Founder
Entrepreneur and CEO with broad experience in business development, organisational leadership and investment strategy across industries of the medical sector. He has supported international growth initiatives and participated in major exits as an investor, focusing on scalable models and sustainable value creation.
CFO & Co-Founder
Entrepreneur and CEO in the medical device industry for over 18 years, with collaborations with leading multinationals such as Cordis (J&J), Siemens, and Philips. He has introduced numerous innovative start-ups to the market and has strong expertise in business development, international expansion and strategic commercial operations.